Meridian Investment Counsel’s iShares US Medical Devices ETF IHI Stock Holding History

Meridian Investment Counsel’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Sell	20,583 -2,324	-10%	-$118K	0.22%	112
2026 Q1	$1.22M	Buy	22,907 +175	+0.8%	+$10.3K	0.29%	100
2025 Q4	$1.41M	Buy	22,732 +395	+2%	+$24.4K	0.34%	88
2025 Q3	$1.34M	Buy	22,337 +1,674	+8%	+$102K	0.33%	87
2025 Q2	$1.29M	Buy	20,663 +625	+3%	+$37.6K	0.35%	82
2025 Q1	$1.21M	Buy	20,038 +600	+3%	+$37.3K	0.36%	85
2024 Q4	$1.13M	Buy	19,438 +15,188	+357%	+$903K	0.34%	83
2024 Q3	$252K	Buy	+4,250	New	+$243K	0.08%	186

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Meridian Investment Counsel's IHI Position: Q2 2026 in Review

Meridian Investment Counsel reduced its iShares US Medical Devices ETF (IHI) stake by 10% in Q2 2026, selling an estimated $118K and leaving 20,583 shares worth $1.02M. The position accounts for 0.22% of the portfolio, ranked #112.

Meridian Investment Counsel first reported a position in IHI in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.41M in Q4 2025. 411 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Meridian Investment Counsel held 20,583 shares of iShares US Medical Devices ETF worth $1.02M as of Q2 2026.
Meridian Investment Counsel sold 2,324 iShares US Medical Devices ETF shares in Q2 2026, an estimated $118K.
iShares US Medical Devices ETF made up 0.22% of Meridian Investment Counsel's portfolio in Q2 2026, its #112 holding.
Meridian Investment Counsel first reported a position in iShares US Medical Devices ETF in Q3 2024 and has held it in 8 quarters since.
Meridian Investment Counsel's iShares US Medical Devices ETF position peaked at $1.41M in Q4 2025.
411 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.